Vaccine safety experts from the World Health Organization (WHO) are set to review the Oxford-AstraZeneca jab, following halt of it’s roll-out by several European countries.
The halt in countries like Spain, Germany, Italy and France is not unconnected to several reports of blood clots developing after the vaccine was administered.
The WHO says it is investigating the reports of blood clots. On Monday, a spokesman said there was “no evidence” that the incidents were linked to the vaccine.
“As soon as WHO has gained a full understanding of these events, the findings and any unlikely changes to current recommendations will be immediately communicated to the public,” WHO spokesman Christian Lindmeier said.
Similarly, The European Medicines Agency (EMA) is also meeting on Tuesday.
The EMA – which is also currently carrying out a review into incidents of blood clots – said the vaccine could continue to be administered.
The agency advises that the benefits of having the vaccine outweigh the risks of any side effects.
